Professional Documents
Culture Documents
Psikologi Kel.23 Adinda&annisa
Psikologi Kel.23 Adinda&annisa
Dosen Pengampuh :
1. Bouvard, M., Fournet, N., Denis, A., Sixdenier, A. & Clark, D. Intrusive thoughts in
patients with obsessive compulsive disorder and non-clinical participants: a comparison
using the International Intrusive Thought Interview Schedule. Cogn. Behav. Ther. 46,
287–299 (2017).
2. Hybel, K. A., Mortensen, E. L., Lambek, R., Højgaard, D. R. M. A. & Thomsen, P. H.
Executive function predicts cognitive-behavioral therapy response in childhood obsessive-
compulsive disorder. Behav. Res. Ther. 99, 11–18 (2017).
3. Williams, M. T., Chapman, L. K., Simms, J. V. & Tellawi, G. Cross‐Cultural
Phenomenology of Obsessive‐Compulsive Disorder. Wiley Handb. Obs. Compuls. Disord.
I, 56–74 (2017).
4. Bhikram, T., Abi-Jaoude, E. & Sandor, P. OCD: Obsessive-compulsive … disgust? The
role of disgust in obsessive-compulsive disorder. J. Psychiatry Neurosci. 42, 300–306
(2017).
5. Shrivastava, A., Kar, S. K., Sharma, E., Mahdi, A. A. & Dalal, P. K. A study of oxidative
stress biomarkers in obsessive compulsive disorder. J. Obsessive. Compuls. Relat. Disord.
15, 52–56 (2017).
6. Sinopoli, V. M., Burton, C. L., Kronenberg, S. & Arnold, P. D. A review of the role of
serotonin system genes in obsessive-compulsive disorder. Neurosci. Biobehav. Rev. 80,
372–381 (2017).
7. Van Ameringen, M., Turna, J., Khalesi, Z., Pullia, K. & Patterson, B. There is an app for
that! The current state of mobile applications (apps) for DSM-5 obsessive-compulsive
disorder, posttraumatic stress disorder, anxiety and mood disorders. Depress. Anxiety 34,
526–539 (2017).
8. Brakoulias, V. et al. Comorbidity, age of onset and suicidality in obsessive–compulsive
disorder (OCD): An international collaboration. Compr. Psychiatry 76, 79–86 (2017).
9. McNally, R. J., Mair, P., Mugno, B. L. & Riemann, B. C. Co-morbid obsessive-
compulsive disorder and depression: A Bayesian network approach. Psychol. Med. 47,
1204–1214 (2017).
10. Apergis-Schoute, A. M. et al. Neural basis of impaired safety signaling in Obsessive
Compulsive Disorder. Proc. Natl. Acad. Sci. U. S. A. 114, 3216–3221 (2017).
11. Menchón, J. M. et al. A prospective international multi-center study on safety and efficacy
of deep brain stimulation for resistant obsessive-compulsive disorder. Mol. Psychiatry 26,
1234–1247 (2021).
12. Carlisi, C. O. et al. Comparison of neural substrates of temporal discounting between
youth with autism spectrum disorder and with obsessive-compulsive disorder. Psychol.
Med. 47, 2513–2527 (2017).
13. Palm, U. et al. Prefrontal tDCS and sertraline in obsessive compulsive disorder: a case
report and review of the literature. Neurocase 23, 173–177 (2017).
14. Donse, L., Sack, A. T., Fitzgerald, P. B. & Arns, M. Sleep disturbances in obsessive-
compulsive disorder: Association with non-response to repetitive transcranial magnetic
stimulation (rTMS). J. Anxiety Disord. 49, 31–39 (2017).
15. Gillan, C. M., Fineberg, N. A. & Robbins, T. W. A trans-diagnostic perspective on
obsessive-compulsive disorder. Psychol. Med. 47, 1528–1548 (2017).
16. Osland, S., Arnold, P. D. & Pringsheim, T. The prevalence of diagnosed obsessive
compulsive disorder and associated comorbidities: A population-based Canadian study.
Psychiatry Res. 268, 137–142 (2018).
17. Norman, L. J. et al. Frontostriatal Dysfunction During Decision Making in Attention-
Deficit/Hyperactivity Disorder and Obsessive-Compulsive Disorder. Biol. Psychiatry
Cogn. Neurosci. Neuroimaging 3, 694–703 (2018).
18. O’Connell, K. S., McGregor, N. W., Lochner, C., Emsley, R. & Warnich, L. The genetic
architecture of schizophrenia, bipolar disorder, obsessive-compulsive disorder and autism
spectrum disorder. Mol. Cell. Neurosci. 88, 300–307 (2018).
19. Kim, S. J. et al. A study of novel bilateral thermal capsulotomy with focused ultrasound
for treatment-refractory obsessive– compulsive disorder: 2-year follow-up. J. Psychiatry
Neurosci. 43, 327–337 (2018).
20. Apergis-Schoute, A. M. et al. Hyperconnectivity of the ventromedial prefrontal cortex in
obsessive-compulsive disorder. Brain Neurosci. Adv. 2, 239821281880871 (2018).
21. Adams, T. G. et al. The Role of Stress in the Pathogenesis and Maintenance of Obsessive-
Compulsive Disorder. Chronic Stress 2, (2018).
22. Boedhoe, P. S. W. et al. Cortical abnormalities associated with pediatric and adult
obsessive-compulsive disorder: Findings from the enigma obsessive-compulsive disorder
working group. Am. J. Psychiatry 175, 453–462 (2018).
23. Bruce, S. L., Ching, T. H. W. & Williams, M. T. Pedophilia-Themed Obsessive–
Compulsive Disorder: Assessment, Differential Diagnosis, and Treatment with Exposure
and Response Prevention. Arch. Sex. Behav. 47, 389–402 (2018).
24. Jones, P. J., Mair, P., Riemann, B. C., Mugno, B. L. & McNally, R. J. A network
perspective on comorbid depression in adolescents with obsessive-compulsive disorder. J.
Anxiety Disord. 53, 1–8 (2018).
25. Marazziti, D., Mucci, F. & Fontenelle, L. F. Immune system and obsessive-compulsive
disorder. Psychoneuroendocrinology 93, 39–44 (2018).
26. Kvale, G. et al. Successfully treating 90 patients with obsessive compulsive disorder in
eight days: The Bergen 4-day treatment. BMC Psychiatry 18, 1–9 (2018).
27. Thorsen, A. L. et al. Emotional Processing in Obsessive-Compulsive Disorder: A
Systematic Review and Meta-analysis of 25 Functional Neuroimaging Studies. Biol.
Psychiatry Cogn. Neurosci. Neuroimaging 3, 563–571 (2018).
28. Oudheusden, L. J. B. Van et al. Chronic obsessive – compulsive disorder : prognostic
factors. (2018).
29. Fatori, D. et al. Adaptive treatment strategies for children and adolescents with Obsessive-
Compulsive Disorder: A sequential multiple assignment randomized trial. J. Anxiety
Disord. 58, 42–50 (2018).
30. Chacon, P. et al. Obsessive-compulsive symptoms in children with first degree relatives
diagnosed with obsessive-compulsive disorder. Rev. Bras. Psiquiatr. 40, 388–393 (2018).
31. Fontenelle, L. F. & Yücel, M. A Clinical Staging Model for Obsessive–Compulsive
Disorder: Is It Ready for Prime Time? EClinicalMedicine 7, 65–72 (2019).
32. Gerentes, M., Pelissolo, A., Rajagopal, K., Tamouza, R. & Hamdani, N. Obsessive-
Compulsive Disorder: Autoimmunity and Neuroinflammation. Curr. Psychiatry Rep. 21,
(2019).
33. Stein, D. J. et al. Obsessive–compulsive disorder. Nat. Rev. Dis. Prim. 5, 1–21 (2019).
34. Perera, M. P. N., Bailey, N. W., Herring, S. E. & Fitzgerald, P. B. Electrophysiology of
obsessive compulsive disorder: A systematic review of the electroencephalographic
literature. J. Anxiety Disord. 62, 1–14 (2019).
35. Abramovitch, A. et al. Body mass index in obsessive-compulsive disorder. J. Affect.
Disord. 245, 145–151 (2019).
36. Abramovitch, A., McCormack, B., Brunner, D., Johnson, M. & Wofford, N. The impact
of symptom severity on cognitive function in obsessive-compulsive disorder: A meta-
analysis. Clin. Psychol. Rev. 67, 36–44 (2019).
37. Baldermann, J. C. et al. Connectivity Profile Predictive of Effective Deep Brain
Stimulation in Obsessive-Compulsive Disorder. Biol. Psychiatry 85, 735–743 (2019).
38. Riesel, A. et al. Error-related brain activity as a transdiagnostic endophenotype for
obsessive-compulsive disorder, anxiety and substance use disorder. Psychol. Med. 49,
1207–1217 (2019).
39. Fineberg, N. A. et al. Early intervention for obsessive compulsive disorder: An expert
consensus statement. Eur. Neuropsychopharmacol. 29, 549–565 (2019).
40. Boedhoe, P. S. W. et al. An Empirical Comparison of Meta- and Mega-Analysis With
Data From the ENIGMA Obsessive-Compulsive Disorder Working Group. Front.
Neuroinform. 12, 1–8 (2019).
41. Kiverstein, J., Rietveld, E., Slagter, H. A. & Denys, D. Obsessive Compulsive Disorder: A
Pathology of Self-Confidence? Trends Cogn. Sci. 23, 369–372 (2019).
42. Ferreri, F. et al. How new technologies can improve prediction, assessment, and
intervention in obsessive-compulsive disorder (e-ocd): Review. JMIR Ment. Heal. 6, 1–15
(2019).
43. Bu, X. et al. Investigating the predictive value of different resting-state functional MRI
parameters in obsessive-compulsive disorder. Transl. Psychiatry 9, (2019).
44. Shabani, M. J. et al. An Iranian study of group acceptance and commitment therapy versus
group cognitive behavioral therapy for adolescents with obsessive-compulsive disorder on
an optimal dose of selective serotonin reuptake inhibitors. J. Obsessive. Compuls. Relat.
Disord. 22, (2019).
45. Barzilay, R. et al. Obsessive-Compulsive Symptomatology in Community Youth: Typical
Development or a Red Flag for Psychopathology? J. Am. Acad. Child Adolesc. Psychiatry
58, 277-286.e4 (2019).
46. Tanir, Y. et al. Exacerbation of obsessive compulsive disorder symptoms in children and
adolescents during COVID-19 pandemic. Psychiatry Res. 293, 3–7 (2020).
47. Aardema, F. COVID-19, obsessive-compulsive disorder and invisible life forms that
threaten the self. J. Obsessive. Compuls. Relat. Disord. 26, 100558 (2020).
48. Chakraborty, A. & Karmakar, S. Impact of COVID-19 on obsessive compulsive disorder
(OCD). Iran. J. Psychiatry 15, 256–259 (2020).
49. Fontenelle, L. F. & Miguel, E. C. The impact of coronavirus (COVID-19) in the diagnosis
and treatment of obsessive-compulsive disorder. Depress. Anxiety 37, 510–511 (2020).
50. Benatti, B. et al. What Happened to Patients With Obsessive Compulsive Disorder During
the COVID-19 Pandemic? A Multicentre Report From Tertiary Clinics in Northern Italy.
Front. Psychiatry 11, 1–5 (2020).
51. Fullana, M. A. et al. Diagnostic biomarkers for obsessive-compulsive disorder: A
reasonable quest or ignis fatuus? Neurosci. Biobehav. Rev. 118, 504–513 (2020).
52. Li, N. et al. A unified connectomic target for deep brain stimulation in obsessive-
compulsive disorder. Nat. Commun. 11, 1–12 (2020).
53. Fineberg, N. A. et al. Since January 2020 Elsevier has created a COVID-19 resource
centre with free information in English and Mandarin on the novel coronavirus COVID-
19 . The COVID-19 resource centre is hosted on Elsevier Connect , the company ’ s
public news and information. Compr. Psychiatry J. 100, 152174 (2020).
54. Shafran, R., Coughtrey, A. & Whittal, M. Recognising and addressing the impact of
COVID-19 on obsessive-compulsive disorder. The Lancet Psychiatry 7, 570–572 (2020).
55. Gürsel, D. A. et al. Frontoparietal and salience network alterations in obsessive–
compulsive disorder: Insights from independent component and sliding time window
analyses. J. Psychiatry Neurosci. 45, 214–221 (2020).
56. Abba-Aji, A. et al. COVID-19 pandemic and mental health: Prevalence and correlates of
new-onset obsessive-compulsive symptoms in a Canadian province. Int. J. Environ. Res.
Public Health 17, 1–11 (2020).
57. Schiele, M. A. et al. Monoamine oxidase a hypomethylation in obsessive-compulsive
disorder: Reversibility by successful psychotherapy? Int. J. Neuropsychopharmacol. 23,
319–323 (2020).
58. Fradkin, I., Adams, R. A., Parr, T., Roiser, J. P. & Huppert, J. D. Searching for an anchor
in an unpredictable world: A computational model of obsessive compulsive disorder.
Psychol. Rev. (2020) doi:10.1037/rev0000188.
59. Smit, D. J. A. et al. Genetic meta-analysis of obsessive–compulsive disorder and self-
report compulsive symptoms. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. 183,
208–216 (2020).
60. Khosravani, V., Samimi Ardestani, S. M., Sharifi Bastan, F. & Malayeri, S. Difficulties in
emotion regulation and symptom dimensions in patients with obsessive-compulsive
disorder. Curr. Psychol. 39, 1578–1588 (2020).
61. Fairbrother, N. F. & Al, C. et. High prevalence and incidence of OCD among women
across pregnancy and the postpartum. 37212, 1–12 (2021).
62. Isomura, K. et al. Risk of specific cardiovascular diseases in obsessive-compulsive
disorder. J. Psychiatr. Res. 135, 189–196 (2021).
63. Acenowr, C. P. & Coles, M. E. OCD during COVID-19: Understanding clinical and non-
clinical anxiety in the community. Psychiatry Res. 300, 113910 (2021).
64. Meșterelu, I., Rîmbu, R., Blaga, P. & Stefan, S. Obsessive-compulsive symptoms and
reactions to the COVID-19 pandemic. Psychiatry Res. 302, 114021 (2021).
65. Schwartz-Lifshitz, M. et al. Obsessive compulsive symptoms severity among children and
adolescents during COVID-19 first wave in Israel. J. Obsessive. Compuls. Relat. Disord.
28, 100610 (2021).
66. GÜRBÜZ, T. et al. Investigating anxiety, depression and obsessive-compulsive disorders
among the pregnant women during Covid-19 pandemic. J. Heal. Sci. Med. 4, 7–12 (2021).
67. Goodman, W. K., Storch, E. A. & Sheth, S. A. Harmonizing the neurobiology and
treatment of obsessive-compulsive disorder. Am. J. Psychiatry 178, 17–29 (2021).
68. Tiley, C. & Kyriakopoulos, M. The prevalence of autism spectrum traits and autism
spectrum disorders in children and adolescents with obsessive compulsive disorder: a
systematic review. BJPsych Open 7, S56–S56 (2021).
69. Fullana, M. A. et al. Diagnostic biomarkers for obsessive-compulsive disorder: A
reasonable quest or ignis fatuus? Neurosci. Biobehav. Rev. 118, 504–513 (2020).
70. Haber, S. N., Yendiki, A. & Jbabdi, S. Four Deep Brain Stimulation Targets for
Obsessive-Compulsive Disorder: Are They Different? Biol. Psychiatry 90, 667–677
(2021).
71. Hilbert, K. et al. Identifying CBT non-response among OCD outpatients: A machine-
learning approach. Psychother. Res. 31, 52–62 (2021).
72. Liu, W., Zhang, H. & He, Y. Variation in obsessive-compulsive disorder symptoms and
treatments: A side effect of covid-19. Int. J. Environ. Res. Public Health 18, (2021).
73. Pinciotti, C. M., Piacsek, K., Kay, B., Bailey, B. & Riemann, B. C. OCD in the time of
COVID-19: A global pandemic’s impact on mental health patients and their treatment
providers. Bull. Menninger Clin. 86, 91–112 (2022).
74. Wadsworth, L. P. et al. Understanding the overlap between OCD and trauma:
development of the OCD trauma timeline interview (OTTI) for clinical settings. Curr.
Psychol. (2021) doi:10.1007/s12144-021-02118-3.
75. Shephard, E. et al. Toward a neurocircuit-based taxonomy to guide treatment of
obsessive–compulsive disorder. Mol. Psychiatry 26, 4583–4604 (2021).
76. Sloover, M., van Est, L. A. C., Janssen, P. G. J., Hilbink, M. & van Ee, E. A meta-analysis
of mentalizing in anxiety disorders, obsessive-compulsive and related disorders, and
trauma and stressor related disorders. J. Anxiety Disord. 92, (2022).
77. Gadot, R. et al. Efficacy of deep brain stimulation for treatment-resistant obsessive-
compulsive disorder: systematic review and meta-analysis. J. Neurol. Neurosurg.
Psychiatry jnnp-2021-328738 (2022) doi:10.1136/jnnp-2021-328738.
78. Schwarzlose, R. F., Hennefield, L., Hoyniak, C. P., Luby, J. L. & Gilbert, K. E. Picky
Eating in Childhood: Associations with Obsessive-Compulsive Symptoms. J. Pediatr.
Psychol. 47, 816–826 (2022).
79. Khan, Y. S. et al. COVID-19 pandemic fears and obsessive-compulsive symptoms in
adolescents with pre-existing mental disorders: An exploratory cross-sectional study. Clin.
Child Psychol. Psychiatry 27, 89–103 (2022).
80. Peeters, N., van Passel, B. & Krans, J. The effectiveness of schema therapy for patients
with anxiety disorders, OCD, or PTSD: A systematic review and research agenda. Br. J.
Clin. Psychol. 61, 579–597 (2022).
81. Li, I. et al. COVID-19 related differences in the uptake and effects of internet-based
cognitive behavioural therapy for symptoms of obsessive-compulsive disorder. Behav.
Cogn. Psychother. 50, 219–236 (2022).
82. Guazzini, A., Gursesli, M. C., Serritella, E., Tani, M. & Duradoni, M. Obsessive-
Compulsive Disorder (OCD) Types and Social Media: Are Social Media Important and
Impactful for OCD People? Eur. J. Investig. Heal. Psychol. Educ. 12, 1108–1120 (2022).
83. Han, S. et al. Two distinct subtypes of obsessive compulsive disorder revealed by
heterogeneity through discriminative analysis. Hum. Brain Mapp. 43, 3037–3046 (2022).
84. Yilmaz, Z. et al. Predicting eating disorder and anxiety symptoms using disorder-specific
and transdiagnostic polygenic scores for anorexia nervosa and obsessive-compulsive
disorder. (2022).
85. Cole, S. N. & Tubbs, P. M. C. Predictors of obsessive – compulsive symptomology : mind
wandering about the past and future. Psychol. Res. 86, 1518–1534 (2022).
86. Pozza, A., Casale, S. & Dèttore, D. Therapists ’ Emotional Reactions to Patients with
Obsessive – Compulsive Disorder : The Role of Therapists ’ Orientation and
Perfectionism. J. Ration. Cogn. Ther. (2022) doi:10.1007/s10942-022-00443-5.
87. Kellner, M. Drug treatment of obsessive-compulsive disorder. (2022)
doi:10.31887/DCNS.2010.12.2/mkellner.
88. Melkonian, M. et al. Symptom improvement and remission in untreated adults seeking
treatment for obsessive-compulsive disorder: A systematic review and meta-analysis. J.
Affect. Disord. 318, 175–184 (2022).
89. Tandt, H. L. N., Van Parys, H., Leyman, L., Purdon, C. & Lemmens, G. M. D. How are
OCD patients and their families coping with the COVID-19 pandemic? A qualitative
study. Curr. Psychol. 41, 505–515 (2022).
90. Brewer, G. & Centifanti, L. Experiences of Mental Distress during COVID-19 : Thematic
Analysis of Discussion Forum Posts for Anxiety , Depression , and Obsessive-
Compulsive Disorder. (2022) doi:10.1177/10541373211023951.